Evidence map›Paper›PMID 35448828›Full record

ArticleTropical medicine and infectious disease2022

Transmission of SARS-CoV-2 in the Population Living in High- and Low-Density Gradient Areas in Dhaka, Bangladesh.

Syed Moinuddin Satter, Taufiqur Rahman Bhuiyan, Zarin Abdullah, Marjahan Akhtar, Aklima Akter, S M Zafor Shafique, Muhammad Rashedul Alam, Kamal Ibne Amin Chowdhury, Arifa Nazneen, Nadia Ali Rimi and 9 more

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. COVID-19: Current Status and Future Prospects.Tropical medicine and infectious disease · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Syed Moinuddin SatterProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka 1212, Bangladesh.
Taufiqur Rahman BhuiyanProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka 1212, Bangladesh.
Zarin AbdullahProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka 1212, Bangladesh.ORCID 0000-0002-5071-2626
Marjahan AkhtarProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka 1212, Bangladesh.
Aklima AkterProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka 1212, Bangladesh.
S M Zafor ShafiqueProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka 1212, Bangladesh.
Muhammad Rashedul AlamProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka 1212, Bangladesh.ORCID 0000-0001-9625-6307
Kamal Ibne Amin ChowdhuryProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka 1212, Bangladesh.ORCID 0000-0001-7125-7071
Arifa NazneenProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka 1212, Bangladesh.
Nadia Ali RimiProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka 1212, Bangladesh.
A S M AlamgirInstitute of Epidemiology, Disease Control & Research, 44 Mohakhali, Dhaka 1212, Bangladesh.
Mahbubur RahmanInstitute of Epidemiology, Disease Control & Research, 44 Mohakhali, Dhaka 1212, Bangladesh.ORCID 0000-0001-8577-8281
Farzana Islam KhanInstitute of Epidemiology, Disease Control & Research, 44 Mohakhali, Dhaka 1212, Bangladesh.
Tahmina ShirinInstitute of Epidemiology, Disease Control & Research, 44 Mohakhali, Dhaka 1212, Bangladesh.ORCID 0000-0002-5061-3783
Meerjady Sabrina FloraDirectorate General of Health Services (DGHS), Mohakhali, Dhaka 1212, Bangladesh.
Sayera BanuProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka 1212, Bangladesh.ORCID 0000-0002-5121-1962
Mustafizur RahmanProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka 1212, Bangladesh.
Mahmudur RahmanGlobal Health Development, EMPHNET, 69 Mohakhali, Dhaka 1212, Bangladesh.
Firdausi QadriProgramme for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka 1212, Bangladesh.

Funding

Bill & Melinda Gates Foundation INV-017556.
6 · The paper itself

Abstract

Community transmission of SARS-CoV-2 in densely populated countries has been a topic of concern from the beginning of the pandemic. Evidence of community transmission of SARS-CoV-2 according to population density gradient and socio-economic status (SES) is limited. In June−September 2020, we conducted a descriptive longitudinal study to determine the community transmission of SARS-CoV-2 in high- and low-density areas in Dhaka city. The Secondary Attack Rate (SAR) was 10% in high-density areas compared to 20% in low-density areas. People with high SES had a significantly higher level of SARS-CoV-2-specific Immunoglobulin G (IgG) antibodies on study days 1 (p = 0.01) and 28 (p = 0.03) compared to those with low SES in high-density areas. In contrast, the levels of seropositivity of SARS-CoV-2-specific Immunoglobulin M (IgM) were comparable (p > 0.05) in people with high and low SES on both study days 1 and 28 in both high- and low-density areas. Due to the similar household size, no differences in the seropositivity rates depending on the population gradient were observed. However, people with high SES showed higher seroconversion rates compared to people with low SES. As no difference was observed based on population density, the SES might play a role in SARS-CoV-2 transmission, an issue that calls for further in-depth studies to better understand the community transmission of SARS-CoV-2.

Indexed as

Bangladeshcommunity transmissionCOVID-19Dhakapopulation density gradientSARS-CoV-2

Identifiers

PMID35448828
PMCPMC9030026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.